HORIZON KINETICS ASSET MANAGEMENT LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
HORIZON KINETICS ASSET MANAGEMENT LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$340,000
-18.1%
67,2000.0%0.01%
-9.1%
Q2 2019$415,000
+33.0%
67,2000.0%0.01%
+22.2%
Q1 2019$312,00067,2000.01%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders